Kristi Lassley, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 145 East Broadway, Drumright, OK 74030 Phone: 918-352-9301 Fax: 918-352-4255 |
News Archive
Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.
A new computer-aided method used with MDCT to detect and measure pneumothoraces in trauma patients helps physicians make quicker and more accurate decisions in busy emergency room settings, according to a study performed at Massachusetts General Hospital and Harvard Medical School in Boston, MA.
The goal of this research was to create an ECM modified hyaluronic acid (HA) based hydrogel culture system that allows for the growth and differentiation of salivary acinar cells into functional acini-like structures capable of secreting large amounts of protein and fluid unidirectionally. Xerostomia, a condition resulting from irradiation of the head and neck, affects more than 40,000 cancer patients each year in the United States. According to this research, these patients will greatly benefit from the development of a functional implantable artificial salivary gland.
Hill-Rom Holdings, Inc. today announced the signing of a definitive agreement to purchase TRUMPF Medical, the medical unit of the privately held TRUMPF Group, for approximately $250 million in cash.
During this year's observance of "World Stroke Day," Thursday, October 29, the American Heart Association and its division, the American Stroke Association, will join international organizations with a unified message about the global threat of stroke.
› Verified 6 days ago